Drug Trial Radar · NCT00640991
REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)
Last checked: Nov 20, 2026Latest source record: Jun 16, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Planned (sponsor's estimate)
Start
Apr 2008
Primary completion
Jun 2010
Study completion Jun 2010
Sponsor
- Lead sponsor
- Population Health Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 21, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Insulin will safely reduce glucose levels in patients with acute ST-elevation myocardial infarction and admission hyperglycemia.
Conditions
- Hyperglycemia
- Cardiovascular Diseases
- Myocardial Infarction
Interventions
glulisine insulin, glargine insulinDrug
IV infusion of glulisine, SC injection of glargine
Primary outcomes
What the sponsor says the trial is designed to measure.
- The 24-hour difference in mean glucose between the two study groups.Time frame: 24 hours
Locations
13 sites in 3 countries. Site status is shown where the registry gives one.
Instituto Medico Adrogue
Adrogué, Buenos Aires, Argentina
Hamilton Health Sciences, General Site
Hamilton, Ontario, Canada
Avanti Institute of Cardiology
Nagpur, India
Assam Medical College Hospital
Dt. Dibrugarh, Assam, India
Lifeworth Super Specialty Hospital
Raipur, Chhattisgarh, India
Post Graduate Institute of Medical
Rohtak, Haryana, India
St. Johns Medical College
Bangalore, Karnataka, India
Nanjappa Hospital
Shimoga, Karnataka, India
Baby Memorial Hospital
Calicut, Kerala, India
Caritas Hospital
Kottayam, Kerala, India
KEM Hospital
Mumbai, Maharashtra, India
MGIMS
Wardha, Maharashtra, India
Railway Hospital
Chennai, Tamil Nadu, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.